None listed
Conditions
Interventions
Intervention1: Ageless WonderTM Facial Muscle Stimulation: Subjects who will receive Device will use 45 minutes per day, for 10 weeks.
Control Intervention1: Ponds cream (sun protection cream): Apply
Sponsors
Vercel Inc
Spectrum Clinical Research Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.35 - 50 years of age.( 40% male and 60% female ) 2.Visual signs of aging on the face with mild/moderate to severe wrinkles. 3.In general good health, •Free of dermatological conditions such as eczema, seborrheic dermatitis and psoriasis. 4.Signing of an Informed Consent Contract in conformance with CFR Part 50: "Protection of Human Subjects". 5.Dependability and intelligence in following directions. 6.Completion of a Panelist Profile/Medical History. 7.Subjects must be willing to maintain their normal diet throughout the duration of the study. 8.Using acceptable methods of birth control.
Exclusion criteria
Exclusion criteria: 1.Pregnant women (or pregnancy within last 3 months). 2.Inadequate precaution or procedure to prevent pregnancy (women of child- bearing potential only). 3.Treatment for any type of cancer within the last six months. 4.Use of any prescribed anti-inflammatory drug, immunosuppressive drugs or antihistamine medication (steroid nose drops and/or eye drops are permitted). Any over-the-counter pain medication that is ingested in quantities exceeding label instructions. 5.Damaged skin in or around test sites which include sunburn, extremely deep tans, uneven skin tones, tattoos, scars, excessive hair, numerous freckles or other disfiguration of the test site. 6.Individuals who have any implanted medical devices (pacemaker, pump, catheter, etc.). 7.Current or history of a medical condition that would contraindicate treatment with the product, such as epilepsy, hernia, abdominal ulcer, diabetes, or other conditions which, in the opinion of the Investigator, would place the participant at risk. 8.A current skin disease of any type at the test site (e.g. acne, eczema, psoriasis, burns, abrasions, etc.) 9.Heavy alcohol consumption in the opinion of the investigator. 10.A fever in the last 12 hours prior to the first application of the test device. 11.History of heart disease. 12.History of stroke. 13.History of malignant disease. 14.Insulin dependent diabetes. 15.Concurrent medication likely to affect the response to the test article or confuse the results of the study (e.g. routine high dose use of any drugs that may artificially affect skin tone). 16.Individuals who are currently participating in any other clinical. Investigation, or who have participated in a study with the same indication within 1 year. 17.Principal investigator for this study, or member of study staff. 18.Participants with skin conditions such as obvious sun damage, increased pigmentation and / or telangectasia. 19.Any dental inflammation or other acute dental condition. 20.Individuals who have had facial surgery. 21.Patients with facial muscle fever.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To improve muscle toning, skin elasticity, firmness, fine line & wrinkle reduction and to reduce the signs of facial aging in healthy adultsTimepoint: 10 weeks after product use | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactMr Bharani Bhaskar
Spectrum Clinical Research Pvt. Ltd.
Outcome results
None listed